A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Clinical trial NCT06961370 · TERMINATED
Trial details
- NCT number
- NCT06961370
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-16
- Primary completion
- 2026-02-03
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.